Chang-Min Choi
0000-0002-2881-4669
Asan Medical Center
4 papers found
Refreshing results…
A phase II , multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (stage III ) who have not progressed following definitive, platinum‐based, chemoradiation therapy ( PLATINUM trial)
Utilization of a Clinical Trial Management System for the Whole Clinical Trial Process as an Integrated Database: System Development
Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry
Utilization of a Clinical Trial Management System for the Whole Clinical Trial Process as an Integrated Database: System Development (Preprint)
Missing publications? Search for publications with a matching author name.